Clinical Trial Update: Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study [NA]

View source ↗

Summary

A clinical trial evaluated the immunomodulatory efficacy of Poplar-type Propolis Dry Extract ESIT12 for upper respiratory tract infections. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Poplar-type Propolis Dry Extract ESIT12 (propolis extract)

Snippet

Sponsor: Fytexia | Conditions: Upper Respiratory Tract Infection (URTI) | NA | Status: COMPLETED